Swiss investment firm Sectoral Asset Management has launched a new biotech strategy, the Variopartner SICAV – Sectoral Biotech Opportunities Fund with initial assets of over $50m (€44.1m). The fund invests in innovative biotech companies and focuses on small and mid caps. Its portfolio consists of 30 high conviction positions and the stock selection applies a bottom-up approach. […]
Read our interactive ezine on developments in SRI/ESG/Sustainability issues.
Beatriz Hernández of atl Capital on the trend towards unconstrained funds.
This special supplement considers developments in SRI/ESG/Sustainability as it relates to both equities and fixed income. It also looks at measurements around adoption of related factors into investment processes.
Lucas Strojny of Advenis Investment Managers cites Brexit challenge to UK-domiciled funds
Loading ...
Zurich ESG Forum 2018 in pictures 
Video highlights from the Frabelux Forum 2018 
AXA IM’s Gideon Smith joins Oslo Roundtable 
Acadian AM’s Mark P. Roemer joins Oslo Roundtable 2018 
Candriam’s Salazar to discuss EM equities at Barcelona Roundtable 